口腔颌面部静脉畸形诊治：经验与进展

doi:10.19438/j.cjoms.2021.02.017

摘要/Abstract

摘要： 静脉畸形是临床上最常见的先天性血管畸形,可发生于全身各个部位。其病变位置及范围的多样性,使得静脉畸形的诊断和治疗富有挑战性。目前,口腔颌面部静脉畸形的治疗方法主要包括硬化治疗、手术治疗、激光治疗等。本文通过对近几年文献的回顾,结合作者经验,对静脉畸形诊断和治疗的相关进展进行了总结。

关键词: 静脉畸形, 脉管畸形, 硬化治疗, 激光治疗, 口腔颌面部

Abstract: Venous malformation is one of the most common types of congenital vascular malformations, which can be found in any location in the body. It is still a challenge to diagnose and treat complicated venous malformations, owing to the diversity of the site and range of diseased regions. There are various treatment approaches for venous malformations in oral and maxillofacial region, such as systemic targeted drugs, open surgery, sclerotherapy, cryoablation and laser photocoagulation. Based on the experience and the recent available literatures, this article summarized the current status and recent progress in diagnosis and treatment of venous malformation of oral and maxillofacial region.

Key words: Venous malformation, Vascular malformation, Sclerotherapy, Laser photocoagulation, Oral and maxillofacial region

中图分类号:

R739.8

吴海威, 于淼, 郑家伟. 口腔颌面部静脉畸形诊治：经验与进展[J]. 中国口腔颌面外科杂志, 2021, 19(2): 186-192.

WU Hai-wei, YU Miao, ZHENG Jia-wei. Treatment of venous malformations in oral and maxillofacial region: clinical experiences, update and challenges[J]. China J Oral Maxillofac Surg, 2021, 19(2): 186-192.

参考文献

[1] Colletti G, Ierardi AM.Understanding venous malformations of the head and neck: a comprehensive insight[J]. Med Oncol, 2017, 34(3):42.
[2] Puig S, Casati B, Staudenherz A, et al.Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy[J]. Eur J Radiol, 2005, 53(1): 35-45.
[3] Kangas J, Natynki M, Eklund L.Development of molecular therapies for venous malformations[J]. Basic Clin Pharmacol Toxicol, 2018, 123(Suppl 5): 6-19.
[4] Seront E, Vikkula M, Boon LM.Venous malformations of the head and neck[J]. Otolaryngol Clin North Am, 2018, 51(1): 173-184.
[5] Legiehn GM, Heran MK.Venous malformations: classification, development, diagnosis, and interventional radiologic management[J]. Radiol Clin North Am, 2008, 46(3): 545-597.
[6] Boon LM, Mulliken B, Enjolras O, et al.Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities[J]. Arch Dermatol, 2004, 140(8): 971-976.
[7] Vikkula M, Boon LM, Mulliken JB.Molecular genetics of vascular malformations[J]. Matrix Biol, 2001, 20(5-6): 327-335.
[8] Cahill AM, Nijs EL.Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology[J]. Cardiovasc Intervent Radiol, 2011, 34(4): 691-704.
[9] Behravesh S, Yakes W, Gupta N, et al.Venous malformations: clinical diagnosis and treatment[J]. Cardiovasc Diagn Ther, 2016, 6(6): 557-569.
[10] Ali S, Mitchell SE.Outcomes of venous malformation sclerotherapy: a review of study methodology and long-term results[J]. Semin Intervent Radiol, 2017, 34(3): 288-293.
[11] Van der Vleuten CJ, Kater A, Wijnen MH, et al. Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review[J]. Cardiovasc Intervent Radiol, 2014, 37(4): 977-989.
[12] Choi DJ, Alomari AI, Chaudry G, et al.Neurointerventional management of low-flow vascular malformations of the head and neck[J]. Neuroimaging Clin N Am, 2009, 19(2): 199-218.
[13] 孙玉环, 车宗刚, 郑家伟. ISSVA 2018脉管异常新分类[J]. 中国口腔颌面外科杂志, 2019, 17(1): 13-19.
[14] Amyere M, Aerts V, Brouillard P, et al.Somatic uniparental isodisomy explains multifocality of glomuvenous malformations[J]. Am J Hum Genet, 2013, 92(2): 188-196.
[15] Vikkula M, Boon LM, Carraway KL, et al.Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2[J]. Cell, 1996, 87(7): 1181-1190.
[16] Dompmartin A, Vikkula M. Boon LM.Venous malformation: update on aetiopathogenesis, diagnosis and management[J]. Phlebology, 2010, 25(5): 224-235.
[17] Nguyen HL, Boon LM, Vikkula M.Genetics of vascular malformations[J]. Semin Pediatr Surg, 2014, 23(4): 221-226.
[18] Dasgupta R, Patel M.Venous malformations[J].Semin Pediatr Surg, 2014, 23(4): 198-202.
[19] Kolokythas A.Vascular malformations and their treatment in the growing patient[J]. Oral Maxillofac Surg Clin North Am, 2016, 28(1): 91-104.
[20] Limaye N, Wouters V, Uebelhoer M, et al.Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations[J]. Nat Genet, 2009, 41(1): 118-124.
[21] Boscolo E, Limaye N, Huang L, et al.Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects[J]. J Clin Invest, 2015, 125(9): 3491-3504.
[22] Wong AL, Haroon ZA, Werner S, et al.Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues[J]. Circ Res, 1997, 81(4): 567-574.
[23] Fiedler U, Krissl T, Koidl S, et al.Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats[J]. J Biol Chem, 2003, 278(3): 1721-1727.
[24] Felcht M, Luck R, Schering A, et al.Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling[J]. J Clin Invest, 2012, 122(6): 1991-2005.
[25] Korpelainen EI, Kärkkainen M, Gunji Y, et al.Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response[J]. Oncogene, 1999, 18(1): 1-8.
[26] Morris PN, Dunmore BJ, Tadros A, et al.Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations[J]. J Mol Med (Berl), 2005, 83(1): 58-63.
[27] Morris PN, Dunmore BJ, Brindle NP.Mutant Tie2 causing venous malformation signals through Shc[J]. Biochem Biophys Res Commun, 2006, 346(1): 335-338.
[28] Tron AE, Arai T, Duda DM, et al.The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7[J]. Mol Cell, 2012, 46(1): 67-78.
[29] McIntyre BA, Brouillard P, Aerts V, et al. Glomulin is predominantly expressed in vascular smooth muscle cells in the embryonic and adult mouse[J]. Gene Expr Patterns, 2004, 4(3): 351-358.
[30] 林晓曦. 血管瘤和脉管畸形的诊疗进展(2018-2019)及关键性问题[J]. 中国口腔颌面外科杂志, 2019, 17(6): 486-495.
[31] Martinez-Lopez A, Salvador-Rodriguez L, Montero-Vilchez T, et al.Vascular malformations syndromes: an update[J]. Curr Opin Pediatr, 2019, 31(6): 747-753.
[32] Dompmartin A, Acher A, Thibon P, et al.Association of localized intravascular coagulopathy with venous malformations[J]. Arch Dermatol, 2008, 144(7): 873-877.
[33] Hung JW, Leung MW, Liu CS, et al.Venous malformation and localized intravascular coagulopathy in children[J]. Eur J Pediatr Surg, 2017, 27(2): 181-184.
[34] Nakano TA, Zeinati C.Venous thromboembolism in pediatric vascular anomalies[J]. Front Pediatr, 2017, 5:158.
[35] Chute C, Stein B, Sylvia MB, et al.Perioperative care of the vascular anomaly patient[J]. Semin Pediatr Surg, 2014, 23(4): 233-237.
[36] Trop I, Dubois J, Guibaud L, et al.Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US[J]. Radiology, 1999, 212(3): 841-845.
[37] Lee BB, Choe YH, Ahn JM, et al.The new role of magnetic resonance imaging in the contemporary diagnosis of venous malformation: can it replace angiography?[J]. J Am Coll Surg, 2004, 198(4): 549-558.
[38] Goyal M, Causer PA, Armstrong D.Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification[J]. Radiology, 2002, 223(3): 639-644.
[39] Triana P, Dore M, Cerezo VN, et al.Sirolimus in the treatment of vascular anomalies[J]. Eur J Pediatr Surg, 2017, 27(1): 86-90.
[40] Maruani A, Boccara O, Bessis D, et al.Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.[J]. Trials, 2018, 19(1): 340-349.
[41] Li J, Kim SG, Blenis J.Rapamycin: one drug, many effects[J]. Cell Metab, 2014, 19(3): 373-379.
[42] Le Sage S, David M, Dubois J, et al.Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: a case series[J]. Pediatr Dermatol, 2018, 35(4): 472-477.
[43] Zhang G, Chen H, Zhen Z, et al.Sirolimus for treatment of verrucous venous malformation: a retrospective cohort study[J]. J Am Acad Dermatol, 2019, 80(2): 556-558.
[44] Johnson JN, Shaughnessy WJ, Stans AA, et al.Management of knee arthropathy in patients with vascular malformations[J]. J Pediatr Orthop, 2009, 29(4): 380-384.
[45] James CA, Braswell LE, Wright LB, et al.Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up[J]. J Vasc Interv Radiol, 2011, 22(7): 953-960.
[46] Tieu DD, Ghodke BV, Vo NJ, et al.Single-stage excision of localized head and neck venous malformations using preoperative glue embolization[J]. Otolaryngol Head Neck Surg, 2013, 148(4): 678-684.
[47] Canter HI, Vargel I, Mavlll ME, et al.Tissue response to N-butyl-2-cyanoacrylate after percutaneous injection into cutaneous vascular lesions[J]. Ann Plast Surg, 2002, 49(5): 520-526.
[48] Zhang J, Li HB, Zhou SY, et al.Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children[J]. Exp Ther Med, 2013, 6(2): 305-309.
[49] 杨耀武, 郑家伟, 孙沫逸, 等. 聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J]. 中国口腔颌面外科杂志, 2018, 16(3): 275-278.
[50] Qiu Y, Chen H, Lin X, et al.Outcomes and complications of sclerotherapy for venous malformations[J]. Vasc Endovascular Surg, 2013, 47(6): 454-461.
[51] Hassan Y, Osman AK, Altyeb A.Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection[J]. Ann Plast Surg, 2013, 70(1): 70-73.
[52] Mohan AT, Adams S, Adams K, et al.Intralesional bleomycin injection in management of low flow vascular malformations in children[J]. J Plast Surg Hand Surg, 2015, 49(2): 116-120.
[53] Cornelis FH, Labreze C, Pinsolle V, et al.Percutaneousimage-guided cryoablation as second-line therapy of soft-tissue venous vascular malformations of extremities: a prospective study of safety and 6-month efficacy[J]. Cardiovasc Intervent Radiol, 2017, 40(9): 1358-1366.
[54] Lu X, Ye K, Shi H, et al.Percutaneous endovenous treatment of congenital extratruncular venous malformations with an ultrasound-guided and 810-nm diode laser[J]. J Vasc Surg, 2011, 54(1): 139-145.
[55] Poetke M, Philipp CM, Urban P, et al.Interstitial laser treatment of venous malformations[J]. Med Laser, 2001, 16(4): 111-119.
[56] 王德明, 苏立新, 范新东, 等. 静脉畸形中国专家共识[J]. 介入放射学杂志, 2019, 28(4): 307-311.